Biohaven Ltd. (BHVN)
NYSE·Healthcare·Biotechnology
$13.39
-2.76%
Mkt Cap $1.56B
Analyst Ratings
Buy
5
Hold
2
Sell
1
Price Target (27 analysts)
$15.40
Range $10.00 – $23.00
Implied Upside
+15.0%
Consensus $15.40 vs current $13.39
NYSE·Healthcare·Biotechnology
$13.39
-2.76%
Mkt Cap $1.56B
Buy
5
Hold
2
Sell
1
Price Target (27 analysts)
$15.40
Range $10.00 – $23.00
+15.0%
Consensus $15.40 vs current $13.39